Method for obtaining nanodispersed systems Application number: EP24382895 Application date: 08/09/2024 Co-owners with Nanomol Technologies SL, Spain and Centro de Investigación Biomédica en Red (CIBER), Spain
Liposomes and its use as enzyme delivery Priority number: EP21382062 PCT publication number: WO/2022/161990 Priority date: 27/01/2021 This patent received Orphan Drug Designation from the European Medicines Agency (EMA) in 2021 for the treatment of Fabry disease.